News
-
-
-
PRESS RELEASE
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
Interim two-year follow-up data from VenoValve pivotal trial show sustained clinical improvement at 24 months compared to baseline. FDA decision expected in 2025 -
-
-
-
-
-
-